These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 34174391)
1. In vivo imaging of synaptic density with [ Xiong M; Roshanbin S; Rokka J; Schlein E; Ingelsson M; Sehlin D; Eriksson J; Syvänen S Neuroimage; 2021 Oct; 239():118302. PubMed ID: 34174391 [TBL] [Abstract][Full Text] [Related]
2. Validation and noninvasive kinetic modeling of [ Bertoglio D; Verhaeghe J; Miranda A; Kertesz I; Cybulska K; Korat Š; Wyffels L; Stroobants S; Mrzljak L; Dominguez C; Liu L; Skinbjerg M; Munoz-Sanjuan I; Staelens S J Cereb Blood Flow Metab; 2020 Jun; 40(6):1351-1362. PubMed ID: 31307287 [TBL] [Abstract][Full Text] [Related]
3. Kinetic evaluation and test-retest reproducibility of [ Finnema SJ; Nabulsi NB; Mercier J; Lin SF; Chen MK; Matuskey D; Gallezot JD; Henry S; Hannestad J; Huang Y; Carson RE J Cereb Blood Flow Metab; 2018 Nov; 38(11):2041-2052. PubMed ID: 28792356 [TBL] [Abstract][Full Text] [Related]
4. Kinetics and 28-day test-retest repeatability and reproducibility of [ Tuncel H; Boellaard R; Coomans EM; de Vries EF; Glaudemans AW; Feltes PK; García DV; Verfaillie SC; Wolters EE; Sweeney SP; Ryan JM; Ivarsson M; Lynch BA; Schober P; Scheltens P; Schuit RC; Windhorst AD; De Deyn PP; van Berckel BN; Golla SS J Cereb Blood Flow Metab; 2021 Jun; 41(6):1338-1350. PubMed ID: 34013797 [TBL] [Abstract][Full Text] [Related]
5. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging. Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain. Nabulsi NB; Mercier J; Holden D; Carré S; Najafzadeh S; Vandergeten MC; Lin SF; Deo A; Price N; Wood M; Lara-Jaime T; Montel F; Laruelle M; Carson RE; Hannestad J; Huang Y J Nucl Med; 2016 May; 57(5):777-84. PubMed ID: 26848175 [TBL] [Abstract][Full Text] [Related]
7. Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [ Vogler L; Ballweg A; Bohr B; Briel N; Wind K; Antons M; Kunze LH; Gnörich J; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Boening G; Ziegler SI; Levin J; Zwergal A; Höglinger GU; Herms J; Brendel M Neuroimage Clin; 2023; 39():103484. PubMed ID: 37541098 [TBL] [Abstract][Full Text] [Related]
8. In Vivo Synaptic Density Imaging with Toyonaga T; Smith LM; Finnema SJ; Gallezot JD; Naganawa M; Bini J; Mulnix T; Cai Z; Ropchan J; Huang Y; Strittmatter SM; Carson RE J Nucl Med; 2019 Dec; 60(12):1780-1786. PubMed ID: 31101744 [No Abstract] [Full Text] [Related]
9. Tracing synaptic loss in Alzheimer's brain with SV2A PET-tracer UCB-J. Kumar A; Scarpa M; Nordberg A Alzheimers Dement; 2024 Apr; 20(4):2589-2605. PubMed ID: 38363009 [TBL] [Abstract][Full Text] [Related]
10. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers. Constantinescu CC; Tresse C; Zheng M; Gouasmat A; Carroll VM; Mistico L; Alagille D; Sandiego CM; Papin C; Marek K; Seibyl JP; Tamagnan GD; Barret O Mol Imaging Biol; 2019 Jun; 21(3):509-518. PubMed ID: 30084043 [TBL] [Abstract][Full Text] [Related]
11. First-in-Human Evaluation of Naganawa M; Li S; Nabulsi N; Henry S; Zheng MQ; Pracitto R; Cai Z; Gao H; Kapinos M; Labaree D; Matuskey D; Huang Y; Carson RE J Nucl Med; 2021 Apr; 62(4):561-567. PubMed ID: 32859701 [TBL] [Abstract][Full Text] [Related]
12. Identification of pre-synaptic density networks using [ Akkermans J; Zajicek F; Miranda A; Adhikari MH; Bertoglio D Neuroimage; 2022 Dec; 264():119771. PubMed ID: 36436710 [TBL] [Abstract][Full Text] [Related]
13. Synaptic density in healthy human aging is not influenced by age or sex: a Michiels L; Delva A; van Aalst J; Ceccarini J; Vandenberghe W; Vandenbulcke M; Koole M; Lemmens R; Laere KV Neuroimage; 2021 May; 232():117877. PubMed ID: 33639258 [TBL] [Abstract][Full Text] [Related]
14. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem. Bertoglio D; Verhaeghe J; Wyffels L; Miranda A; Stroobants S; Mrzljak L; Dominguez C; Skinbjerg M; Bard J; Liu L; Munoz-Sanjuan I; Staelens S J Nucl Med; 2022 Jun; 63(6):942-947. PubMed ID: 34531262 [TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET. Thomsen MB; Jacobsen J; Lillethorup TP; Schacht AC; Simonsen M; Romero-Ramos M; Brooks DJ; Landau AM J Cereb Blood Flow Metab; 2021 Apr; 41(4):819-830. PubMed ID: 32538280 [TBL] [Abstract][Full Text] [Related]